TMI 1
Chemical Name: (3S)-4-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-3-thiomorpholinecarboxamide
Purity: ≥98%
Biological Activity
TMI 1 is an ADAM17 (TACE) and MMP inhibitor (IC50 values are 3, 4.7, 6.6, 8.4, 12, 26 and 26 nM for MMP-13, MMP-2, MMP-1, ADAM 17, MMP-9, MMP-7 and MMP-14, respectively). Suppresses TNF-α production in an acute LPS-mouse model. Reduces severity score in an in vivo model of rheumatoid arthritis. Displays selective cytotoxicity to tumor cells and cancer stem cells in vitro. Induces tumor apoptosis in a breast cancer in vivo model. Orally bioavailable.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
CD44 Interacts with HIF-2? to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells
E Johansson, ES Grassi, V Pantazopou, B Tong, D Lindgren, TJ Berg, EJ Pietras, H Axelson, A Pietras
Cell Rep, 2017;20(7):1641-1653. -
Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer
Mezil et al.
PLoS One, 2012;7:e43409 -
Heterocyclic inhibitors of tumor necrosis factor-α converting enzyme (TACE)
Levin
Heterocycles, 2006;70:691 -
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-α-converting enzyme/matrix meta
Zhang et al.
J.Pharmacol.Exp.Ther., 2004;309:348
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for TMI 1
The citations listed below are publications that use Tocris products. Selected citations for TMI 1 include:
2 Citations: Showing 1 - 2
-
Dendritic Cell-Restricted Progenitors Contribute to Obesity-Associated Airway Inflammation via Adam17-p38 MAPK-Dependent Pathway.
Authors: J Philip Et al.
Front Immunol 2020;11:363
-
The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release.
Authors: Bent Et al.
Am J Pathol 2017;187:2388-2398
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for TMI 1
There are currently no reviews for this product. Be the first to review TMI 1 and earn rewards!
Have you used TMI 1?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image